Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism
Michèle Tinazzi(University of Verona), Sarah Ottaviani(Provincia Autonoma di Trento), Tommaso Bovi(University of Verona), Angelo Antonini(University of Padua), Giuseppe Moretto(University of Verona), Isabella Pasquin(Provincia Autonoma di Trento), Antonio Fiaschi(University of Verona), Maria Steinmayr(Provincia Autonoma di Trento)
Cited by 68
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease
|European Journal of Neurology|2012|490
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
|Movement Disorders|2023|351
Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations
|Journal of the Neurological Sciences|2003|258
Pain as a Nonmotor Symptom of Parkinson Disease
|Archives of Neurology|2008|243